Bionovate Technologies Corp
BIIO · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $238 | $237 | $231 | $201 |
| Enterprise Value | $238 | $237 | $231 | $202 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$6 | -$4 | -$17 | -$21 |
| % Margin | – | – | – | – |
| Net Income | -$22 | -$20 | -$32 | -$32 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.003 | -0.005 | -0.001 | -0.001 |
| % Growth | 37.8% | -542.9% | -16.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |